-
Mashup Score: 2AUA2024
Darolutamide uptake in metastatic hormone-sensitive prostate cancer has become routine both in doublet and triplet regimens in community urology practices.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3ENDO2024CoDI Video Contest - 10 hour(s) ago
Are you interested in making a difference in these areas? If so, we encourage you to apply for the Future of Endocrinology Competition!
Source: www.endocrine.orgCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 3AUA2024TAR-210 Demonstrates Preliminary Efficacy in FGFR-Altered Non–Muscle-Invasive Bladder Cancer - 11 hour(s) ago
TAR-210 was safe and showed promising clinical activity in patients with FGFR-altered high- and intermediate-risk non–muscle-invasive bladder cancer.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2AUA2024
Alexander Kutikov, MD, FACS, discusses treatment options for patients with urothelial cancer requiring cystectomy.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0ENDO2024CoDI Video Contest - 16 hour(s) ago
Are you interested in making a difference in these areas? If so, we encourage you to apply for the Future of Endocrinology Competition!
Source: www.endocrine.orgCategories: General Medicine News, EndocrinologyTweet
Darolutamide Use Is Routine in Both Doublets and Triplet Therapies in mHSPC. @UrologyCentAL #AUA2024 https://t.co/kSJ8I7uGCQ